Melinda Sue Noble

Melinda Noble practices at Joint Base Elmendorf-Richardson 673rd Medical Group in Jber, Alaska, part of United States Department of War.

Melinda Noble's NPI, 1477063568, was assigned on October 3, 2017. Melinda Noble holds Alaska license 125786.

Melinda Noble's primary practice is Joint Base Elmendorf-Richardson 673rd Medical Group, at 673 Mdg 5955 Zeamer Ave, Jber, AK 99506 in Anchorage Borough. The practice phone is (907) 384-1110. Melinda Noble also practices at Joint Base Elmendorf Richardson Mtf, 5955 Zeamer Ave, Jber, AK 99506.

Melinda Noble's primary practice is Joint Base Elmendorf-Richardson 673rd Medical Group in Jber, Alaska, part of United States Department of War. Melinda Noble is also affiliated with Providence Alaska Medical Center. The medical group on file is Select Physical Therapy. Dmand AI also links Melinda Noble to 1 more hospital, 2 group practices and clinics, 1 breast imaging center, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Melinda Noble practices, 7 sites in all. Vendor and product names are available with a free account.

Family is Melinda Noble's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Melinda Noble is licensed in Alaska.

CMS counts 257 Medicare patients who saw Melinda Noble in 2024. The largest group is 65 to 74, with 125 patients. 64% of them have high blood pressure, and 57% have high cholesterol. 14% are also on Medicaid. Their average risk score is 0.79, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Melinda Noble's median patient age at 58, with 66% women.

In 2024, Melinda Noble wrote 2,813 Medicare Part D claims for 195 patients. 85% of them were for generic drugs.

Melinda Noble accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 19 general payments to Melinda Noble from 7 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $209.